Change in end systolic volume plus reduction in symptoms over 12 months [clinicaltrials_resource:f0f6b3634e4e4694bbc3c46545cbd2ea]

Change in end systolic volume plus reduction in symptoms over 12 months [clinicaltrials_resource:f0f6b3634e4e4694bbc3c46545cbd2ea]

Targeted LV lead placement
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]
http://bio2rdf.org/clinicaltrials_resource:f0f6b3634e4e4694bbc3c46545cbd2ea
Effect of Targeting Left Ventricular Lead Position on the Rate of Response to Cardiac Resynchronization Therapy. [clinicaltrials:NCT00399594]
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]

Change in end systolic volume plus reduction in symptoms over 12 months [clinicaltrials_resource:f0f6b3634e4e4694bbc3c46545cbd2ea]

Targeted LV lead placement
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]
http://bio2rdf.org/clinicaltrials_resource:f0f6b3634e4e4694bbc3c46545cbd2ea
Bio2RDF identifier
f0f6b3634e4e4694bbc3c46545cbd2ea
Bio2RDF namespace
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:f0f6b3634e4e4694bbc3c46545cbd2ea
measure [clinicaltrials_vocabulary:measure]
Change in end systolic volume plus reduction in symptoms
time frame [clinicaltrials_vocabulary:time-frame]
description
Targeted LV lead placement
identifier
clinicaltrials_resource:f0f6b3634e4e4694bbc3c46545cbd2ea
title
Change in end systolic volume plus reduction in symptoms over 12 months
@en
inDataset
type
label
Change in end systolic volume ...... 6b3634e4e4694bbc3c46545cbd2ea]
@en